SCHEMBL6982684

SCHEMBL6982684

CCOC(=O)CN(Cc1ccccc1)c1ccc2c(c1)CCCN2C(=O)CCc1ccc(C#N)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 4/20 0.43
NR3C1 P04150 1/20 0.42
NOTUM Q6P988 1/20 0.40
F2 P00734 2/20 0.40
F10 P00742 2/20 0.40
ITGB3 P05106 2/20 0.40
ITGA2B P08514 2/20 0.40
AR P10275 1/20 0.39
PARP1 P09874 1/20 0.39
ALDH1A1 P00352 3/20 0.39
MEN1 O00255 2/20 0.39
HPGD P15428 2/20 0.39
KMT2A Q03164 2/20 0.39
NPC1 O15118 1/20 0.39
MAPT P10636 1/20 0.39
MAPK1 P28482 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PDK1 Q15118 1/20 0.38
PDK2 Q15119 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6985390 0.93 ALDH1A1 (0.40) KDM1ANR3C1NOTUMF2F10
SCHEMBL6985609 0.90 NOTUM (0.39) NR3C1NOTUMPARP1ALDH1A1MEN1
SCHEMBL6979167 0.89 KDM1A (0.47) KDM1ANR3C1ARPARP1ALDH1A1
SCHEMBL6980751 0.89 NOTUM (0.44) NR3C1NOTUMF2F10ITGB3
SCHEMBL6984161 0.89 PARP1 (0.39) KDM1ANR3C1NOTUMF2F10
SCHEMBL6980094 0.88 KDM1A (0.42) KDM1ANR3C1ARPARP1ALDH1A1
SCHEMBL6984164 0.88 KDM1A (0.43) KDM1ANR3C1ARALDH1A1MEN1
Hydrochloric Acid SCHEMBL6977886 0.87 F2 (0.51) NOTUMF2F10ITGB3ITGA2B
SCHEMBL7958945 0.87 PDK1 (0.41) NR3C1NOTUMF2F10ITGB3
SCHEMBL6977074 0.87 KDM1A (0.45) KDM1ANR3C1ALDH1A1MEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed